The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
Arcus Biosciences Inc COM 03969F109 54,386 5,049,786 SH   DFND 2 0 5,049,786 0
Arris Intl Inc SHS G0551A103 232,439 7,603,500 SH   DFND 1 0 7,603,500 0
Autolus Therapeutics PLC SPON ADS 05280R100 23,450 714,072 SH   DFND 2 0 714,072 0
Cloudera Inc COM 18914U100 4,730 427,710 SH   DFND 2 0 427,710 0
Dexcom Inc COM 252131107 3,266 110,457 SH   DFND   0 110,457 0
DocuSign Inc COM 256163106 45,199 1,127,714 SH   DFND 2 0 1,127,714 0
DocuSign Inc COM 256163106 1,746 43,570 SH   DFND   0 43,570 0
Dropbox Inc CL A 26210C104 266 13,033 SH   DFND 2 0 13,033 0
Evelo Biosciences Inc COM 299734103 13,797 1,060,495 SH   DFND 2 0 1,060,495 0
Forty Seven Inc COM 34983P104 24,303 1,545,966 SH   DFND 2 0 1,545,966 0
Gritstone Oncology Inc COM 39868T105 14,353 929,022 SH   DFND 2 0 929,022 0
JD com Inc SPON ADR CL A 47215P106 283,674 13,553,474 SH   DFND 1 0 13,553,474 0
Magenta Therapeutics Inc COM 55910K108 19,033 3,339,138 SH   DFND 2 0 3,339,138 0
Snap Inc CL A 83304A106 14,428 2,618,548 SH   DFND   0 2,618,548 0
Spero Therapeutics Inc COM 84833T103 6,842 1,112,473 SH   DFND 2 0 1,112,473 0
Square Inc CL A 852234103 692 12,342 SH   DFND 1 0 12,342 0
SVMK Inc COM 78489X103 56,549 4,608,705 SH   DFND   0 4,608,705 0
Zscaler Inc COM 98980G102 46,648 1,189,688 SH   DFND   0 1,189,688 0